144 related articles for article (PubMed ID: 24790085)
1. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
Figarska SM; Vonk JM; Boezen HM
Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
[TBL] [Abstract][Full Text] [Related]
2. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
[TBL] [Abstract][Full Text] [Related]
3. ADAM33 gene polymorphisms and mortality. A prospective cohort study.
Figarska SM; Vonk JM; van Diemen CC; Postma DS; Boezen HM
PLoS One; 2013; 8(7):e67768. PubMed ID: 23861802
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China.
Xu X; Sun J; Chang X; Wang J; Luo M; Wintergerst KA; Miao L; Cai L
J Cell Mol Med; 2016 Nov; 20(11):2078-2088. PubMed ID: 27374075
[TBL] [Abstract][Full Text] [Related]
5. NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.
Sandford AJ; Malhotra D; Boezen HM; Siedlinski M; Postma DS; Wong V; Akhabir L; He JQ; Connett JE; Anthonisen NR; Paré PD; Biswal S
Physiol Genomics; 2012 Aug; 44(15):754-63. PubMed ID: 22693272
[TBL] [Abstract][Full Text] [Related]
6. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.
Figarska SM; Boezen HM; Vonk JM
Eur J Epidemiol; 2012 Nov; 27(11):867-76. PubMed ID: 23054033
[TBL] [Abstract][Full Text] [Related]
7. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
[TBL] [Abstract][Full Text] [Related]
8. Association of NFE2L2 Gene Polymorphisms with Risk and Clinical Characteristics of Acute Type A Aortic Dissection in Han Chinese Population.
Zhang Y; Zheng Q; Chen R; Dai X; Zhu Y; Ma L
Oxid Med Cell Longev; 2021; 2021():5173190. PubMed ID: 34336095
[TBL] [Abstract][Full Text] [Related]
9. Is anti-tuberculosis drug-induced hepatotoxicity due to a change in pharmacokinetics caused by alterations in antioxidant gene expression and polymorphisms in the
Ji G; Huang W; He J
Int J Clin Pharmacol Ther; 2020 Feb; 58(2):67-73. PubMed ID: 31670652
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
11. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Genetic Variations in
Santos LR; Durães C; Ziros PG; Pestana A; Esteves C; Neves C; Carvalho D; Bongiovanni M; Renaud CO; Chartoumpekis DV; Habeos IG; Simões MS; Soares P; Sykiotis GP
Thyroid; 2019 Sep; 29(9):1302-1315. PubMed ID: 31426718
[No Abstract] [Full Text] [Related]
13. Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up.
Taghizadeh N; Vonk JM; Boezen HM
PLoS One; 2016; 11(4):e0153310. PubMed ID: 27055053
[TBL] [Abstract][Full Text] [Related]
14. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
[TBL] [Abstract][Full Text] [Related]
15. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
[TBL] [Abstract][Full Text] [Related]
16. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
[TBL] [Abstract][Full Text] [Related]
17. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
[TBL] [Abstract][Full Text] [Related]
18. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN
Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182
[TBL] [Abstract][Full Text] [Related]
19. Functional Polymorphism in the
Ji G; Zhang M; Liu Q; Wu S; Wang Y; Chen G; Sandford AJ; He JQ
Front Immunol; 2021; 12():660384. PubMed ID: 34108963
[TBL] [Abstract][Full Text] [Related]
20. Second-hand smoke and NFE2L2 genotype interaction increases paediatric asthma risk and severity.
Johansson E; Martin LJ; He H; Chen X; Weirauch MT; Kroner JW; Khurana Hershey GK; Biagini JM
Clin Exp Allergy; 2021 Jun; 51(6):801-810. PubMed ID: 33382170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
